Vaccination with live-attenuated or live vaccines is not recommended during treatment and should be administered at least four weeks before starting<unk> .
Satralizumab
Caplacizumab
Brolucizumab
Natalizumab
Ixekizumab
Tocilizumab
Benralizumab
Ravulizumab